跳至主要内容
临床试验/NCT01576705
NCT01576705已完成3 期

Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children

Institut Jerome Lejeune1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2012年4月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
175
试验地点
1
主要终点
GMDS (Griffiths Mental Development Scale)

研究概览

简要总结

Evaluation of the following in very young children with Down syndrome:

  • the efficacy of systematic treatment with L-thyroxine at controlled doses (clinically and by ultrasensitive thyreostimulating hormone (TSH) assay),
  • the efficacy of systematic folinic acid treatment at a dose of 1 mg/kg/o.i.d,
  • any interaction between these two treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 18 Months(Child)
性别
All
接受健康志愿者

入选标准

  • patient with a karyotype demonstrating homogeneous, free or Robertsonian translocation trisomy 21
  • patient having undergone a cardiac ultrasound not demonstrating any severe heart disease
  • patient aged 6 to 18 months at inclusion

排除标准

  • congenital hypothyroidism
  • hypothyroidism demonstrated by laboratory tests (TSH > 7mUI/l)
  • presenting or having presented hyperthyroidism
  • presenting or having presented leukaemia
  • presenting or having presented West syndrome or any other form of epilepsy or unstable neurological disease
  • presenting or having presented signs of central nervous system distress: stroke, postoperative hypoxia, meningitis)
  • presenting severe heart disease on cardiac ultrasound, with haemodynamic effects
  • presenting non-controlled cardiac arrhythmia
  • Apgar < 7 to 5 min at birth
  • Gestational age < 231 days (33 gestation weeks)

研究组 & 干预措施

Thyroxin + folinic acid

Experimental

干预措施: thyroid hormone and folinic acid (Drug)

Thyroxin+folinic acid placebo

Active Comparator

干预措施: thyroid hormone and folinic acid (Drug)

Thyroxin placebo+ folinic acid

Active Comparator

干预措施: thyroid hormone and folinic acid (Drug)

Thyroxin placebo+ folinic acid placebo

Placebo Comparator

干预措施: thyroid hormone and folinic acid (Drug)

结局指标

主要结局

GMDS (Griffiths Mental Development Scale)

时间窗: 12 months

GMDS for testing and estimate babies psychomotor development from birth to 2 years trough six subscales : Locomotor, Personal-social, Hearing and language, Eye-Hand coordination, Performance.Sub- and General Quotients (GDQ) standard score are based on a mean of 100 and a standard deviation of 16. For children with delayed development, which is the case for children with Down Syndrome, Quotient tables could be not used because sub- and General quotient floors at 50. For each subscale, a raw score was derived from the contributing items. Total raw score was obtained by adding subscale raw scores. Sum of all subscale raw scores was converted into a development age using correspondence table. Subscale and global development quotients were computed by dividing the development age by the chronological age multiplied by 100. For preterm infants, chronological age was corrected taking into account the gestational term. Higher QD's scores show a better psychomotor development outcome

次要结局

  • BL (Brunet Lezine Revised Scale)(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
3 期
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesChildhood Acute Basophilic LeukemiaChildhood Acute Eosinophilic LeukemiaChildhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)Childhood Acute Monoblastic Leukemia (M5a)Childhood Acute Monocytic Leukemia (M5b)Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myelomonocytic Leukemia (M4)Childhood Myelodysplastic Syndromesde Novo Myelodysplastic SyndromesSecondary Acute Myeloid LeukemiaSecondary Myelodysplastic SyndromesUntreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
NCT00369317Children's Oncology Group205
已完成
不适用
Clinical evaluation of the effects of paediatric dental general anaesthesia and midazolam sedation on cognitive function, anxiety and access to future dental careDental caries requiring multiple extractionsOral HealthCaries
ISRCTN12026431Scottish Executive Chief Scientist Office (UK)200
已完成
3 期
Effectiveness Of Neurodevelopmental Treatment In Improving Dynamic Balance In Stroke Patients
CTRI/2017/02/007909Sancheti Institute College of Physiotherapy34
已完成
不适用
Paediatric onset study to assess the efficacy of insulin pump therapy using the MiniMed Paradigm® REAL-Time system during the first year of diabetes in children and adolescents with type 1 diabetesType 1 diabetes mellitus
ISRCTN05450731Hannover Childrens Hospital (Hannoversche Kinderheilanstalt) (Germany)160
尚未招募
不适用
Comparative study of Neuro-Developmental Treatment and Electrical stimulation in cerebral palsy children.
CTRI/2022/02/039899A